Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2019
Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host DiseasePaul J Martin, Barry E Storer, Jeanne Palmer, et al.
Psychosomatic Medicine|September 7, 2023
Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell TransplantationAasha I Hoogland, Brian D Gonzalez, Jong Y Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantationJanelle B Perkins, Jongphil Kim, Claudio Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) IndexJoseph A Pidala, Betty K Hamilton, Paul J Martin, et al.
Blood Advances|July 22, 2026
Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD developmentJoseph A Pidala, Betty K Hamilton, George Liwei Chen, et al.
Blood Advances|September 14, 2021
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD ConsortiumZachariah DeFilipp, Amin M Alousi, Joseph A Pidala, et al.
Blood Advances|January 4, 2020
Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fasciaYoshihiro Inamoto, Stephanie J Lee, Lynn E Onstad, et al.
JAMA Dermatology|January 21, 2026
Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host DiseaseVarshini Babu, Daniel B Shin, Lynn Onstad, et al.
Transplantation and Cellular Therapy|July 30, 2023
Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National RegistryNancy Gillis, Eric Padron, Tao Wang, et al.
Blood Advances|November 25, 2025
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts OutcomesDavid A Sallman, Amy F McLemore, Rami S Komrokji, et al.
Pageof 5